Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake

Schreibman, 1975, Human adipocyte cholesterol. Concentration, localization, synthesis, and turnover, J Clin Invest, 55, 986, 10.1172/JCI108028 Krause, 1984, Adipose tissue and cholesterol metabolism, J Lipid Res, 25, 97, 10.1016/S0022-2275(20)37830-5 Kovanen, 1975, Regulation of cholesterol synthesis and storage in fat cells, J Lipid Res, 16, 211, 10.1016/S0022-2275(20)36728-6 Dagher, 2003, HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes, J Lipid Res, 44, 1811, 10.1194/jlr.M300267-JLR200 Le Lay, 2001, Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes, J Biol Chem, 276, 16904, 10.1074/jbc.M010955200 Cuffe, 2018, Targeted deletion of adipocyte Abca1 (ATP-binding cassette transporter A1) impairs diet-induced obesity, Arterioscler Thromb Vasc Biol, 38, 733, 10.1161/ATVBAHA.117.309880 Luo, 2020, Mechanisms and regulation of cholesterol homeostasis, Nat Rev Mol Cell Biol, 21, 225, 10.1038/s41580-019-0190-7 Mukherjee, 1958, The esterification of cholesterol with palmitic acid by rat liver homogenates, J Biol Chem, 230, 91, 10.1016/S0021-9258(18)70543-7 Chang, 1993, Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells, J Biol Chem, 268, 20747, 10.1016/S0021-9258(19)36846-2 Meiner, 1997, Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice, J Lipid Res, 38, 1928, 10.1016/S0022-2275(20)37168-6 Cases, 1998, ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization, J Biol Chem, 273, 26755, 10.1074/jbc.273.41.26755 Chang, 2009, Acyl-coenzyme A:cholesterol acyltransferases, Am J Physiol Endocrinol Metab, 297, E1, 10.1152/ajpendo.90926.2008 Lee, 2000, Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates, J Lipid Res, 41, 1991, 10.1016/S0022-2275(20)32360-9 Parini, 2004, ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver, Circulation., 110, 2017, 10.1161/01.CIR.0000143163.76212.0B Shibuya, 2015, ACAT1/SOAT1 as a therapeutic target for Alzheimer’s disease, Future Med Chem, 7, 2451, 10.4155/fmc.15.161 Yang, 2016, Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism, Nature., 531, 651, 10.1038/nature17412 Zabielska, 2019, Acyl-coenzyme A:cholesterol acyltransferase inhibition in cancer treatment, Anticancer Res, 39, 3385, 10.21873/anticanres.13482 Song, 2006, Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma, Biochem J, 394, 617, 10.1042/BJ20051417 Burnett, 2002, Avasimibe Pfizer, Curr Opin Investig Drugs, 3, 1328 Llaverias, 2003, Pharmacology of the ACAT inhibitor avasimibe (CI-1011), Cardiovasc Drug Rev, 21, 33, 10.1111/j.1527-3466.2003.tb00104.x Tardif, 2004, Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions, Circulation., 110, 3372, 10.1161/01.CIR.0000147777.12010.EF Robertson, 2001, Preclinical safety evaluation of avasimibe in beagle dogs: an ACAT inhibitor with minimal adrenal effects, Toxicol Sci, 59, 324, 10.1093/toxsci/59.2.324 Lee, 1996, Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets, J Med Chem, 39, 5031, 10.1021/jm960674d Ramharack, 1998, CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys, Atherosclerosis., 136, 79, 10.1016/S0021-9150(97)00189-5 Burnett, 1999, Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs, J Lipid Res, 40, 1317, 10.1016/S0022-2275(20)33494-5 Insull, 2001, Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia, Atherosclerosis., 157, 137, 10.1016/S0021-9150(00)00615-8 Raal, 2003, Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia, Atherosclerosis., 171, 273, 10.1016/j.atherosclerosis.2003.07.011 Lee, 2015, Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment, ACS Nano, 9, 2420, 10.1021/nn504025a Yue, 2014, Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness, Cell Metab, 19, 393, 10.1016/j.cmet.2014.01.019 Li, 2018, Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation, PLoS One, 13 Jiang, 2019, Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma, Nature., 567, 257, 10.1038/s41586-019-0987-8 Bandyopadhyay, 2017, Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia, PLoS One., 12, 10.1371/journal.pone.0179558 Huttunen, 2010, The acyl-coenzyme A:cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice, J Neuropathol Exp Neurol, 69, 777, 10.1097/NEN.0b013e3181e77ed9 Huttunen, 2009, Inhibition of acyl-coenzyme A:cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway, FASEB J, 23, 3819, 10.1096/fj.09-134999 Zhu, 2018, In vitro exploration of ACAT contributions to lipid droplet formation during adipogenesis, J Lipid Res, 59, 820, 10.1194/jlr.M081745 Xu, 2019, Enhanced acyl-CoA:cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function, J Biol Chem, 294, 19306, 10.1074/jbc.RA119.011160 Henagan, 2014, Dietary quercetin supplementation in mice increases skeletal muscle PGC1alpha expression, improves mitochondrial function and attenuates insulin resistance in a time-specific manner, PLoS One., 9, 10.1371/journal.pone.0089365 Murphy, 2010, Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models, Gut., 59, 1635, 10.1136/gut.2010.215665 Kim, 2015, Dietary selenate attenuates adiposity and improves insulin sensitivity in high-fat diet-induced obese mice, J Funct Foods, 17, 33, 10.1016/j.jff.2015.05.008 Xue, 2009, Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice, Gastroenterology., 136, 1317, 10.1053/j.gastro.2008.12.051 Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia., 28, 412, 10.1007/BF00280883 Wallace, 2004, Use and abuse of HOMA modeling, Diabetes Care, 27, 1487, 10.2337/diacare.27.6.1487 Kleinert, 2018, Animal models of obesity and diabetes mellitus, Nat Rev Endocrinol, 14, 140, 10.1038/nrendo.2017.161 Datta, 2018, Fat fibrosis: friend or foe?, JCI Insight, 3, 10.1172/jci.insight.122289 Huang, 2018, Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity, Am J Physiol Endocrinol Metab, 315, E340, 10.1152/ajpendo.00174.2017 Lin, 2016, Adipose extracellular matrix remodelling in obesity and insulin resistance, Biochem Pharmacol, 119, 8, 10.1016/j.bcp.2016.05.005 Reilly, 2017, Adapting to obesity with adipose tissue inflammation, Nat Rev Endocrinol, 13, 633, 10.1038/nrendo.2017.90 Bi, 2019, Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma, Oncol Lett, 18, 1548 Li, 2016, Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer, Oncogene., 35, 6378, 10.1038/onc.2016.168 Delsing, 2001, Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice, Circulation., 103, 1778, 10.1161/01.CIR.103.13.1778 Post, 1999, Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat, Hepatology., 30, 491, 10.1002/hep.510300230 Pan, 2019, Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator, EBioMedicine., 49, 72, 10.1016/j.ebiom.2019.10.044 Xu, 2018, Sterol O-acyltransferase 1 deficiency improves defective insulin signaling in the brains of mice fed a high-fat diet, Biochem Biophys Res Commun, 499, 105, 10.1016/j.bbrc.2018.02.122 Dietschy, 2004, Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal, J Lipid Res, 45, 1375, 10.1194/jlr.R400004-JLR200 Puglielli, 2003, Alzheimer’s disease: the cholesterol connection, Nat Neurosci, 6, 345, 10.1038/nn0403-345 Block, 2010, Altered cholesterol and fatty acid metabolism in Huntington disease, J Clin Lipidol, 4, 17, 10.1016/j.jacl.2009.11.003 Suzuki, 2010, Diabetes and insulin in regulation of brain cholesterol metabolism, Cell Metab, 12, 567, 10.1016/j.cmet.2010.11.006 Korade, 2008, Lipid rafts, cholesterol, and the brain, Neuropharmacology., 55, 1265, 10.1016/j.neuropharm.2008.02.019 McDaniel, 2012, Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to alpha-melanocyte-stimulating hormone (alpha-MSH), J Biol Chem, 287, 21873, 10.1074/jbc.M112.346890 Koza, 2006, Changes in gene expression foreshadow diet-induced obesity in genetically identical mice, PLoS Genet, 2, 10.1371/journal.pgen.0020081 Lim, 2013, Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E epsilon3 and epsilon4 knock-in mice, Neurobiol Aging, 34, 2217, 10.1016/j.neurobiolaging.2013.03.012 Bryleva, 2010, ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD, Proc Natl Acad Sci U S A, 107, 3081, 10.1073/pnas.0913828107 Hutter-Paier, 2004, The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer’s disease, Neuron., 44, 227, 10.1016/j.neuron.2004.08.043 Shibuya, 2019, Brain targeting of acyl-CoA:cholesterol O-acyltransferase-1 inhibitor K-604 via the intranasal route using a hydroxycarboxylic acid solution, ACS Omega, 4, 16943, 10.1021/acsomega.9b02307